Component

3,4-O-Isopropylidene shikimic acid / ISA

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. The isopropylidene-shikimic-acid record is a distinct-compound or preparation comparison; its biological effects are not assigned to isolated shikimic acid.

    Experimental context and source evidence
    evidence_access
    Primary indexed abstract reviewed; full results, tables and supplements not independently extracted.
    experimental_model
    Editorial identity/scope connection, not experimental causation.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    Unsigned navigation, not a human metabolic conversion or automatic ingredient attribution.
    plain_language
    The isopropylidene-shikimic-acid record is a distinct-compound or preparation comparison; its biological effects are not assigned to isolated shikimic acid.
    primary_references
    Anti-inflammatory, analgesic and antioxidant activities of 3,4-oxo-isopropylidene-shikimic acid. | 2016 | DOI 10.3109/13880209.2016.1153663 | PMID 27609150 | https://pubmed.ncbi.nlm.nih.gov/27609150/ | https://doi.org/10.3109/13880209.2016.1153663
    primary_references
    Anti-platelet and anti-thrombotic effects of triacetylshikimic acid in rats. | 2002 | DOI 10.1097/00005344-200202000-00013 | PMID 11791012 | https://pubmed.ncbi.nlm.nih.gov/11791012/ | https://doi.org/10.1097/00005344-200202000-00013
    primary_references
    Protective effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis induced by trinitrobenzenesulfonic acid in rats. | 2012 | DOI 10.1007/s10620-012-2155-y | PMID 22476587 | https://pubmed.ncbi.nlm.nih.gov/22476587/ | https://doi.org/10.1007/s10620-012-2155-y
    source_locator
    Reviewed reference lines 57-57; exact primary location described in quoted passage where extracted.

    Shikimic acid: detailed mechanisms of action (reviewed 5 October 2026) · lines 57–57

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Editorial identity/scope connection, not experimental causation. · source_derived_draft · unverified_draft

    **Derivatives keep their own outcomes.** Triacetylshikimic acid (TSA) reduced stimulated platelet aggregation and shunt thrombosis in rat experiments; reported cAMP increased, while cGMP, thromboxane/prostacyclin metabolites and clotting-time endpoints included null results. Those results are not assigned to parent shikimic acid. The separately tested 3,4-O-isopropylidene derivative (ISA) has rodent inflammatory/pain studies and cell-free radical-scavenging assays. Structural similarity does not establish interchangeable pharmacokinetics, targets or safety. [Anti-platelet and anti-thrombotic effects of triacetylshikimic acid in rats.](https://pubmed.ncbi.nlm.nih.gov/11791012/) [Protective effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis induced by trinitrobenzenesulfonic acid in rats.](https://pubmed.ncbi.nlm.nih.gov/22476587/) [Anti-inflammatory, analgesic and antioxidant activities of 3,4-oxo-isopropylidene-shikimic acid.](https://pubmed.ncbi.nlm.nih.gov/27609150/)
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.